U.S. spot Bitcoin ETP approval

Jana reads that America has approved bitcoin funds. Does that mean the regulator recommends buying bitcoin? Order 34-99306 of January 10, 2024 says something more precise: it approved 11 proposals from NYSE Arca, Nasdaq and Cboe BZX concerning rules to list and trade the named products. Listing means admitting a security to an exchange. The decision opened a path to buying shares through securities-market infrastructure, not to risk-free returns. It did not require every broker to offer every product, nor does the order alone prove that all products began trading on the same day. [1]

First distinguish the exchange seeking to admit a security to trading from the issuer offering it to investors. The exchange’s proposal goes through the process under Rule 19b-4. Registration of the offering under the 1933 Act and of the securities under the 1934 Act has its own requirements. A beginner need not memorize those numbers; the useful point is that completing one step does not replace the others. An effective registration statement is not a judgment that an investment is good. The prospectus explains the product, its costs and risks, while the actual trading launch must be checked separately. [1] [3]

Approval followed an earlier legal dispute. In its January statement, the SEC referred to the Grayscale case: the court found that the regulator had not adequately explained its previous rejection of the proposed product. It vacated that rejection and sent the matter back to the SEC for reconsideration. The important distinction is between reviewing the agency’s reasoning and assessing an investment for Jana. The court did not certify the safety of BTC, take responsibility for its price, or replace every product-specific requirement. It challenged the decision’s reasoning rather than guaranteeing a future investment outcome. [2]

The regulator also considered how fraud and market manipulation could be detected. It examined how closely price changes move together in the spot market, where bitcoin itself is traded, and in CME futures, contracts for future settlement. This tendency to move together is called correlation. Correlation is not causation: it does not by itself tell us which market drives the other. The reasoning was that manipulation affecting spot prices would likely also affect CME prices, where surveillance and information sharing between exchanges could help detect its effects. That did not put every spot platform under CME surveillance or eliminate manipulation risk. [1]

A broker’s screen may say ETF, short for exchange-traded fund. That abbreviation alone does not define investor protection. Investor.gov explains that US spot bitcoin ETPs are commodity trusts: structures holding underlying assets for shareholders. They are not investment companies registered under the 1940 Act, even if ETF appears in their names. The entire framework applying to ordinary funds under that law cannot therefore be assumed to apply to them. They still have registration, disclosure and antifraud obligations. They are neither free of rules nor legally identical to every other product called an ETF. [3]

Another step came on July 29, 2025, when the SEC permitted in-kind creations and redemptions. In-kind means transferring the underlying asset, BTC for a bitcoin product, instead of settling only in cash. This mechanism is for authorized participants, or APs: contractual counterparties creating or redeeming large blocks of shares with the product. Permission does not prove immediate implementation in a particular product’s agreements and operations. Nor does an ordinary brokerage purchase turn Jana into an AP. The decision alone therefore gives her no right to have the underlying BTC sent to her own address. [4]

Consider an example without fees. Net asset value per share, NAV, remains 50 USD. Market demand nevertheless leads Jana to buy a share for 52 USD, and later she sells it for 50 USD. She loses 2 USD, about 3.85% of her purchase price, although NAV has not changed. She paid a premium, a price above the value of the underlying assets, and that premium later disappeared. In practice, fees and the spread, the difference between buying and selling quotes, can also affect the result. Trading approval does not protect the price paid or guarantee that a share can always be sold for its underlying asset value. [3]

The SEC’s January decision was not an endorsement of BTC, a certification of flawless custody or advance approval of every future crypto product. It allowed specific trading within a particular legal framework. Jana still needs practical answers: What does the product actually hold, who safeguards the assets, how are fees charged, and what rights does her share provide? Those answers belong in the current prospectus and product reports. Availability through a broker may make a purchase easier, but it does not establish whether Jana understands the risks or whether the investment suits her. [2] [3]